LB Pharmaceuticals, Inc. (LBRX)
39.42
+0.19
(+0.48%)
USD |
NASDAQ |
Oct 22, 16:00
39.77
+0.35
(+0.89%)
After-Hours: 20:00
LB Pharmaceuticals Shareholders Equity (Quarterly) : 332.35M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 332.35M |
| March 31, 2026 | 378.69M |
| December 31, 2025 | 301.31M |
| September 30, 2025 | 310.22M |
| June 30, 2025 |
| Date | Value |
|---|---|
| March 31, 2025 | |
| December 31, 2024 | 19.70M |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | 63.81M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 967.52M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 361.69M |
| Total Liabilities (Quarterly) | 29.34M |
| Debt to Equity Ratio | 0.0157 |
| Current Ratio | 15.08 |
| Net Debt Paydown Yield | -0.11% |